193 related articles for article (PubMed ID: 24437177)
21. Antibiotic therapy for Helicobacter pylori.
Collins J; Ali-Ibrahim A; Smoot DT
Med Clin North Am; 2006 Nov; 90(6):1125-40. PubMed ID: 17116440
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori: New Thoughts and Practices.
Shiotani A; Graham DY
Gastroenterol Clin North Am; 2015 Sep; 44(3):xv-xvi. PubMed ID: 26314679
[No Abstract] [Full Text] [Related]
23. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Gisbert JP; McNicholl AG
Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
[No Abstract] [Full Text] [Related]
24. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
25. [New S3 guideline of DGVS for eradication of Helicobacter pylori--recommendations for routine general practice. Focus on the stomach bacterium].
MMW Fortschr Med; 2009 May; 151(22):48-9. PubMed ID: 19526970
[No Abstract] [Full Text] [Related]
26. Helicobacter pylori diagnostics and treatment: could a lack of universal consensus be the best consensus?
Couturier MR; Marshall BJ; Goodman KJ; Mégraud F
Clin Chem; 2014 Apr; 60(4):589-94. PubMed ID: 23908455
[No Abstract] [Full Text] [Related]
27. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
28. [Update Helicobater pylori--what has changed?].
Fischbach W
MMW Fortschr Med; 2012 Apr; 154(7):99-101. PubMed ID: 22558885
[No Abstract] [Full Text] [Related]
29. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation.
Bourke B; Ceponis P; Chiba N; Czinn S; Ferraro R; Fischbach L; Gold B; Hyunh H; Jacobson K; Jones NL; Koletzko S; Lebel S; Moayyedi P; Ridell R; Sherman P; van Zanten S; Beck I; Best L; Boland M; Bursey F; Chaun H; Cooper G; Craig B; Creuzenet C; Critch J; Govender K; Hassall E; Kaplan A; Keelan M; Noad G; Robertson M; Smith L; Stein M; Taylor D; Walters T; Persaud R; Whitaker S; Woodland R;
Can J Gastroenterol; 2005 Jul; 19(7):399-408. PubMed ID: 16010300
[TBL] [Abstract][Full Text] [Related]
30. [Helicobacter pylori--diagnosis and treatment].
Bornschein J; Selgrad M; Malfertheiner P
MMW Fortschr Med; 2011 Sep; 153(38):58-61; quiz 62. PubMed ID: 21977798
[No Abstract] [Full Text] [Related]
31. By the way, doctor. I was treated for two weeks with antibiotics and a proton pump inhibitor when I had an H.pylori infection. I've continued with the proton inhibitor to cut down on stomach acid. Could that be harmful?
Komaroff AL
Harv Health Lett; 2008 Jul; 33(9):8. PubMed ID: 18777657
[No Abstract] [Full Text] [Related]
32. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children.
Koletzko S; Jones NL; Goodman KJ; Gold B; Rowland M; Cadranel S; Chong S; Colletti RB; Casswall T; Elitsur Y; Guarner J; Kalach N; Madrazo A; Megraud F; Oderda G;
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):230-43. PubMed ID: 21558964
[TBL] [Abstract][Full Text] [Related]
33. Guidelines for treatment of Helicobacter pylori in the East and West.
Selgrad M; Bornschein J; Malfertheiner P
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):581-8. PubMed ID: 21819326
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori infection: detection, investigation, and management.
Czinn SJ
J Pediatr; 2005 Mar; 146(3 Suppl):S21-6. PubMed ID: 15758899
[TBL] [Abstract][Full Text] [Related]
35. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
37. [Helicobacter pylori resistance].
Alimoradi J; Rasmussen L; Andersen LP
Ugeskr Laeger; 2010 May; 172(20):1516-21. PubMed ID: 20483098
[TBL] [Abstract][Full Text] [Related]
38. Renewed focus on preventing gastric cancer.
Jenks S
J Natl Cancer Inst; 2015 Jan; 107(1):501. PubMed ID: 25564606
[No Abstract] [Full Text] [Related]
39. Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.
Ang TL; Wang L; Ang D; Chiam P; Fock KM; Teo EK
J Dig Dis; 2013 Feb; 14(2):100-4. PubMed ID: 23253473
[TBL] [Abstract][Full Text] [Related]
40. Novel anti-Helicobacter pylori therapies.
Shahid SK
Pharm Pat Anal; 2014 Jul; 3(4):411-27. PubMed ID: 25291314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
